Our team of experts is dedicated to helping you achieve your weight loss goals through safe and effective treatments
[DOI] [PubMed] [Google Scholar] 14.Muscogiuri G., Cignarelli A., Giorgino F., Prodam F., Santi D., Tirabassi G., Balercia G., Modica R., Faggiano A., Colao A
Safety Considerations and Regulatory Warnings Melanotan II remains unapproved, and products sold through unregulated channels may have uncertain identity, content, purity, sterility, and storage history
Novo Nordisk, Hims & Hers settle GLP-1 drug dispute Kimberly Redmond 9, 2026// The basics: Novo Nordisk, Hims & Hers resolve GLP-1 drug lawsuit Wegovy, Ozempic to be offered on Hims & Hers platform Hims & Hers agrees to stop selling compounded semaglutide FDA-backed deal expands access to approved weight-loss drugs Novo Nordisk and Hims & Hers have ended a legal feud with an agreement that allows the telehealth platform to sell the pharma giants blockbuster brand-name GLP-1 drugs
